Kristian Reckzeh

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cancer research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kim Theilgaard-Mönch, Sachin Pundhir, Kristian Reckzeh, Jinyu Su, Marta Cecylia Tapia, Benjamin Furtwängler, Johan Jendholm, Janus Schou Jakobsen, Marie Sigurd Hasemann, Kasper Jermiin Knudsen, Jack Bernard Cowland, Anna Fossum, Erwin M Schoof, Mikkel Bruhn Schuster, Bo Torben Porse
Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation : In memoriam Professor Niels Borregaard. Nature communications 13 (1) (2022)
Anders Centio, Montserrat Estruch Alrich, Kristian Reckzeh, Kumar Sanjiv, Camilla Vittori, Sophia Engelhard, Ulrika Warpman Berglund, Thomas Helleday, Kim Theilgaard-Mönch
Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML. Molecular cancer therapeutics 21 (5) (2022)
Anamarija Pfeiffer, Giulia Franciosa, Marie Locard-Paulet, Ilaria Piga, Kristian Reckzeh, Vidyasiri Vemulapalli, Stephen C Blacklow, Kim Theilgaard-Mönch, Lars Juhl Jensen, Jesper Velgaard Olsen
Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML. Cancer research 82 (11) (2022)
Kristian Reckzeh, Montserrat Estruch, Mina Ali, Alexandra Søgaard Helbo, Anna Mosbech, Kyoung Jae Won, Frank Rücker, Konstanze Döhner, Kim Theilgaard-Mönch
TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event. British journal of haematology 197 (2) (2022)
Montserrat Estruch Alrich, Kristian Reckzeh, Camilla Vittori, Anders Centio, Mina Ali, Sophia Engelhard, Ling Zhao, Kyoung Jae Won, Paul Liu, Bo Torben Porse, Kim Theilgaard-Mönch
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy. Leukemia 35 (7) (2020)
Kristian Reckzeh, Hüsün Kizilkaya, Alexandra Søgaard Helbo, Montserrat Estruch Alrich, André Gundersen Deslauriers, Amit Grover, Nicolas Rapin, Fazila Asmar, Kirsten Grønbaek, Bo Torben Porse, Niels Borregaard, Dietmar Vestweber, Claus Nerlov, Kim Theilgaard-Mönch
Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin. Blood advances 2 (13) (2019)